Cantor Fitzgerald Starts Spero Therapeutics (SPRO) at Overweight

October 28, 2026 6:03 AM EDT Send to a Friend
(Updated - October 28, 2026 7:25 AM EDT)

Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Spero Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login